Vanthys Pharmaceutical Development (P) Ltd is a 50:50 joint venture of Eli Lilly and Company (USA) and Jubilant Organosys (India). Vanthys was incorporated in May 2009 and is an autonomous organization with the mission of accelerating global drug development. Vanthys is modeled after Lilly's early-stage development division, Chorus (www.choruspharma.com), which provides fast and efficient drug development exclusively through the utilization of external contract companies.
The goal of Vanthys is to provide proof of concept answers during early phase drug development, with the ultimate aim to provide high quality scientific answers to our business partners faster, and in a cost effective manner, so as to aid in decisions for further investment and advancement of the compound.
Please Contact Us to learn more.
